Cynthia De Luise, MPH, PhD

Pfizer Inc

Poster(s):

• (264) A Non-Interventional Study Using Multiple Data Sources to Evaluate Potential Sight Threatening Events and Severe Visual Loss Among Patients Exposed to Crizotinib
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (280) Adapting to The Dynamic Landscape of the COVID-19 Pandemic: Proposed Study Design Approaches for a Postauthorization Safety Study for Pfizer-BioNTech COVID-19 Vaccine in the United States
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (AT) Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study Among Individuals in The Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
  Sunday, August 28, 2022

  8:00 AM – 1:15 PM CEST

• (296) Study of Myocarditis and Pericarditis Following Vaccination with COMIRNATY in Persons Under 21 Years of Age
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (301) VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST